Patents by Inventor Danyu Lin

Danyu Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF IDENTIFYING RISK OF BEVACIZUMAB-INDUCED PROTEINURIA AND HYPERTENSION
    Publication number: 20210395833
    Abstract: The disclosure relates to methods of identifying subjects at risk of developing bevacizumab-induced toxicities such as proteinuria and/or hypertension involving measuring nucleic acid or gene mutations in a sample obtained from the subject.
    Type: Application
    Filed: May 6, 2021
    Publication date: December 23, 2021
    Inventors: Federico Innocenti, Julia Quintanilha, Danyu Lin, Kouros Owzar, Jin Wang
  • Methods of identifying risk of vascular endothelial growth factor (VEGF) pathway inhibitor-induced hypertension
    Patent number: 11028448
    Abstract: The disclosure relates to methods of identifying subjects at risk of developing bevacizumab-induced toxicities such as proteinuria and/or hypertension involving measuring nucleic acid or gene mutations in a sample obtained from the subject.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: June 8, 2021
    Assignees: The University of North Carolina at Chapel Hill, Duke University
    Inventors: Federico Innocenti, Julia Quintanilha, Danyu Lin, Kouros Owzar, Jin Wang
  • METHODS OF IDENTIFYING RISK OF BEVACIZUMAB-INDUCED PROTEINURIA AND HYPERTENSION
    Publication number: 20210085745
    Abstract: The disclosure relates to methods of identifying subjects at risk of developing bevacizumab-induced toxicities such as proteinuria and/or hypertension involving measuring nucleic acid or gene mutations in a sample obtained from the subject.
    Type: Application
    Filed: July 17, 2020
    Publication date: March 25, 2021
    Inventors: Federico Innocenti, Julia Quintanilha, Danyu Lin, Kouros Owzar, Jin Wang